By Cort Johnson in Health Rising.
The similarities are striking: the symptoms, the shoddy research funding, the poor treatment from doctors, the gender imbalance and the stigma both still face. Both diseases still really exist on the fringes of medicine and medical research.
Yet one disease is moving forward rapidly and the other is not – and it’s probably not the one you think.
That disease has a great name.. That disease has three FDA drugs approved for it, a specialty it fits in (however awkwardly) and a home at the National Institutes of Health (NIH). The other disease has a putrid name, has no FDA drugs approved (and none in the pipeline), no specialty associated with it, no home at the NIH, and its community has a (mostly undeserved) reputation for being hard to deal with.
To read the rest of this story, click on the link below: